Commission Decision of 10/09/2018 declaring a concentration to be compatible with the common market (Case No COMP/M.8956 - Biogen / Samsung Biologics / Bioepis) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)
Maintenance EN
Please note that this website will be undergoing technical maintenance between 28 and 31 August. Consequently, users may experience instabilities and limited functionality. We apologise for the inconvenience.
Web Content Display (Global)
Publication Detail Actions Portlet
custom-survey-notification
Publication Detail Portlet

Publication detail

Home
Pop up window annotations
Publication Viewer

Document viewer